Technical Information
Technical Information
Current: Home > News > Technical Information
FDA's ability to provide effective regulatory review of biological products
View: 541  Form: JZSW  Date: 2015-04-16

 Blood cells

Research is fundamental to FDA's ability to provide effective regulatory review of biological products. A wide variety of rapidly evolving technical and scientific issues concerning the safety, potency, and efficacy of new biological products requires knowledge of new developments in basic research in the relevant biological disciplines.

For this reason, FDA scientists in our Center for Biologics Evaluation and Research (CBER) conduct a variety of mission-related programs, including research into allergenicsbloodcellular and gene therapy, andvaccines, to name a few. This research broadens FDA's knowledge of fundamental biological processes and provides a robust scientific base for regulatory review.

In this Web section you will find information on some of the research programs conducted by CBER scientists and their published scientific articles.

CBER also offers research job opportunities in the form of research fellowships and staff positions.

ShenZhen Jianbamboo Biotechnology Co. Ltd  © Copyright 2024 all rights reserved
Address: China Lucky Lu Feng, Longgang District, Block A 2310,2311 Pro ZIP: 518000 WEB Support:YIQ
TEL: +86-755-89218889
QQ Skype